A Peek Into the Future: Will Serial Multimarker Testing Help Bring a New Era of Precision Medicine in Heart Failure Patients?

Circ Heart Fail. 2023 Jan;16(1):e010156. doi: 10.1161/CIRCHEARTFAILURE.122.010156. Epub 2022 Nov 21.

Authors

James A Alzate^{1

2}, Pradeep S Rajendran^{1

2}, Hanna K Gaggin^{3

2}

Affiliations

¹ Department of Medicine (J.A.A., P.S.R.), Massachusetts General Hospital, Boston, MA.
² Harvard Medical School, Boston, MA (J.A.A., P.S.R., H.K.G.).
³ Division of Cardiology, Corrigan Minehan Heart Center (H.K.G.), Massachusetts General Hospital, Boston, MA.

PMID: 36408700
DOI: 10.1161/CIRCHEARTFAILURE.122.010156

No abstract available

Keywords: Editorials; GDF-15; NTproBNP; biomarkers; heart failure; hospitalization; precision medicine; prognosis.

Publication types

Editorial
Comment

MeSH terms

Biomarkers
Heart Failure* / diagnosis
Heart Failure* / therapy
Humans
Natriuretic Peptide, Brain
Peptide Fragments
Precision Medicine
Prognosis

Substances

Biomarkers
Natriuretic Peptide, Brain
Peptide Fragments